Health Care Supplies

INT MEDICAL

Shanghai Yingtai Medical Instruments Acquiring 23.18% Stake in Valgen Holding Corporation

E-Tech Medical Plans to Acquire Part of Valgen Holding for Up to 1.5 Billion Yuan

Eternal Medical Acquires 35% Equity in Pulian Medical to Enhance Operational Efficiency

Yingtai Medical Reports Revenue and Profit Growth in 2025, Pays Dividend of 23 Cents

INT MEDICAL released FY2025 9 Months Earnings on March 27, 2026 (BJT) with actual revenue of HKD 829.58 M and actual EPS of HKD 0.9887

INT MEDICAL released FY2025 Q3 earnings on March 27 Post-Market (BJT), actual revenue HKD 330.36 M, actual EPS HKD 0.3767

INT MEDICAL released FY2025 Q4 earnings on March 27 After-Market (BJT), actual revenue HKD 336.06 M, actual EPS HKD 0.3832

INT MEDICAL released FY2025 earnings on March 27 After-Market (BJT), actual revenue HKD 1.165 B (forecast HKD 1.102 B), actual EPS HKD 1.3722 (forecast HKD 1.2574)

INT MEDICAL to Release FY2025 Annual Earnings on March 27 After-Market (BJT), Forecast Revenue HKD 1.102 B, EPS HKD 1.2574

Eternal Medical Successfully Conducts Placement of 35.2 Million Shares

E&T Medical Issuing 35.2 Million Placement Shares to Raise HK$884 Million

INT MEDICAL released FY2025 Q1 earnings on August 28, 2025 (BJT) with actual revenue of HKD 246.9M and EPS of HKD 0.3026

INT MEDICAL released FY2025 Semi-Annual Earnings on August 28 After-Market (BJT), Actual Revenue HKD 499.23 M, Actual EPS HKD 0.612

INT MEDICAL released FY2025 Q2 earnings on August 28 After-Market (BJT), actual revenue HKD 252.33 M, actual EPS HKD 0

INT MEDICAL FY2025 Semi-Annual Earning Release on August 28, 2025 (BJT)

China Orient Asset Management Increases Holding in YingTai Medical to 17%

E-Tech Medical Acquires 81.83% Equity in Hangzhou Weiqiang Medical Technology

INT MEDICAL released FY2024 Q3 earnings on March 18, 2025 (BJT), with actual revenue of HKD 254.74 M and EPS of HKD 0.2905

INT MEDICAL released FY2024 9-month earnings on March 18 (BJT), actual revenue HKD 678.12 M, actual EPS HKD 0.9101

INT MEDICAL released FY2024 annual earnings on March 18 After-Market (BJT), actual revenue 922.22 M HKD (forecast 1.064 B HKD), actual EPS 1.1904 HKD (forecast 1.2602 HKD)

I.CENTURY HLDG

RIVERINE CHINA

KOS TALENT GP

CHINA CBS INTL

NATURE ENERGY T

DIGIT HOLLYWOOD

REDCO HEALTHY

ZXZN QI-HOUSE

ASIA PIONEER

HUISHENG INTL

Ordinary dividend (cash)

Ex Date: 2026.06.03, Cash dividend 0.26 HKD

01501

02291

SCIENTECH announced its full-year results for the year ended December last year, with a revenue of RMB 528 million, an increase of 11.9% year-on-year. The net profit was RMB 240 million, a decrease of 2.4% year-on-year; earnings per share were RMB 0.69. A final dividend of RMB 0.5 was declared, compared to RMB 0.62 in the same period last year

AASTOCKS

SCIENTECH

"Performance" Scientech Medical's annual net profit is 240 million RMB, down 2.4%, with a final dividend of 0.5 RMB

INT MEDICAL announced its 2025 annual performance, with revenue of 1.065 billion RMB, an increase of 25.1% year-on-year. It recorded a net profit of 219 million RMB, a growth of 14%, with earnings per share of 1.26 RMB. A final dividend of 0.23 RMB was declared

"Performance" INT MEDICAL's annual net profit is 219 million RMB, an increase of 14%, with a final dividend of 32 cents

02216

BRONCUS-B rose over 9% during the session, and as of the time of writing, it is up 5.86%, priced at HKD 3.25, with a transaction volume of HKD 11.7892 million. In terms of news, BRONCUS announced that it plans to issue a total of 105 million subscription shares at a price of HKD 3.11 per share, which represents a premium of about 1.3% over the closing price of the previous trading day. The net proceeds are expected to be approximately HKD 327 million, intended for the continued expansion of its product portfolio through potential acquisitions in the medical device industry. The company has been seeking potential acquisition targets in the medical device sector and is currently in communication with various parties. Notably, in this placement, INT MEDICAL plans to invest approximately HKD 283 million to subscribe for about 91.0936 million shares of BRONCUS. The announcement stated that considering BRONCUS's rich product line in the non-vascular interventional field, the subscription could further expand the company's strategic layout in the non-vascular interventional area

Zhitong

BRONCUS-B

Understanding the Market | BRONCUS-B rose over 9% during the session, planning to raise approximately HKD 327 million through a premium placement, with INT MEDICAL subscribing to the majority of the shares

INT MEDICAL announced that it subscribed for a total of 91.0936 million new shares of BRONCUS-B at a total price of HKD 283.3 million, equivalent to a price of HKD 3.11 per share, which is a premium of 1.3% compared to BRONCUS's closing price on the last trading day (10). Upon completion, the company will hold 14.42% of BRONCUS's equity (excluding treasury shares)

INT MEDICAL invested 283 million yuan to acquire 14.42% of BRONCUS-B

INT MEDICAL plans to subscribe for approximately 91.0936 million shares of BRONCUS-B at a price of HKD 3.11 per share, totaling around HKD 283 million. Upon completion, INT MEDICAL will hold approximately 17.24% of the shares of BRONCUS-B. This subscription will assist INT MEDICAL in its strategic layout in the non-vascular intervention field

INT MEDICAL plans to invest approximately HKD 283 million to subscribe for about 91.0936 million shares of BRONCUS-B

INT MEDICAL(01501.HK)

"Performance" Scientech Medical's annual net profit is 240 million RMB, down 2.4%, with a final dividend of 0.5 RMB

"Performance" INT MEDICAL's annual net profit is 219 million RMB, an increase of 14%, with a final dividend of 32 cents

Understanding the Market | BRONCUS-B rose over 9% during the session, planning to raise approximately HKD 327 million through a premium placement, with INT MEDICAL subscribing to the majority of the shares

INT MEDICAL invested 283 million yuan to acquire 14.42% of BRONCUS-B

INT MEDICAL plans to invest approximately HKD 283 million to subscribe for about 91.0936 million shares of BRONCUS-B

Trending